SCHAFFER PAUL W. purchased 18.6% of their position (25K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $62.7K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/9/2020ACC: 0001437749-20-019524
Director
Since May 2019
+25K
Net shares
Net buyer
$62.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
25K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.77K
Price / share
$2.51
Trade value
$62.16K
% of position
18.4%
9/4/2020
134.42K→159.19K
Common Stock
Direct
Shares
+225.00
Price / share
$2.55
Trade value
$573.75
% of position
0.1%
9/8/2020
159.19K→159.42K
Total
Net shares
+25K
Net value
$62.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2020 | P · Purchase | +24.77K | $2.51 | $62.16K | 18.4% | 134.42K | 159.19K |
| Common Stock Direct | 9/8/2020 | P · Purchase | +225.00 | $2.55 | $573.75 | 0.1% | 159.19K | 159.42K |
| Total | +25K | $62.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned30.66K
Total
30.66K indirect30.66K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 30.66K | Indirect |
| Total | 30.66K | 30.66K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported